This trial was conducted at the Pusan National University Hospital, Pusan Korea in conjunction with RNL bio Co Ltd from January 2009 to April 2011. 20 subjects suffering from Peripheral Vascular Disease with Critical Limb Ischaemia were given intramuscular injections of autologous adipose derived stem cells. Major adverse events were recorded at baseline, 3, 6 & 12 months after the injection as the primary outcome. Ankle Brachial Index, Digital Subtraction Angiography, Treadmill Test and visual analogue pain scores were recorded at the same intervals as the secondary outcome.